A Case of Advanced Gastric Cancer with Poor Performance Status Which Improved by Chemotherapy by Kohei Shitara, Daisuke Takahari

Get full text

Next-generation sequencing and biomarkers for gastric cancer: what is the future? by Akihito Kawazoe, Kohei Shitara

Get full text

Development of circulating tumour DNA analysis for gastrointestinal cancers by Kohei Shitara, Yoshiaki Nakamura

Get full text

Trastuzumab deruxtecan for the treatment of patients with HER2-positive gastric cancer by Daisuke Kotani, Kohei Shitara

Get full text

Zolbetuximab for Claudin18.2-positive gastric or gastroesophageal junction cancer by Yohei Kubota, Kohei Shitara

Get full text

Pancreatic pseudocysts due to a lymph node metastasis: a case report by Kohei Shitara, Kazuo Hara, Yozo Satoh

Get full text

The New Era of Immunotherapy in Gastric Cancer by Shogo Takei, Akihito Kawazoe, Kohei Shitara

Get full text

Neoadjuvant chemotherapy for locally advanced gastric cancer in Japan: Consensus meeting at the 77th general meeting of the Japanese Society of Gastroenterological Surgery by Masanori Tokunaga, Yukinori Kurokawa, Takeo Fukagawa, Kei Muro, Kohei Shitara, Yasuhiro Kodera, Masanori Terashima

Get full text

Tuberculous Meningitis during Chemotherapy for Advanced Gastric Cancer by Hiroshi Matsumoto, Akinori Sasaki, Yoshiaki Nakamura, Akihito Kawazoe, Yasutoshi Kuboki, Keiji Okinaka, Kohei Shitara

Get full text

Retrospective cohort study of nanoparticle albumin-bound paclitaxel plus ramucirumab versus paclitaxel plus ramucirumab as second-line treatment in patients with advanced gastric c... by Mashiro Okunaka, Daisuke Kotani, Ken Demachi, Akihito Kawazoe, Takayuki Yoshino, Toshikatsu Kawasaki, Kohei Shitara

Get full text

Cetuximab plus FOLFOX for Patients with Metastatic Colorectal Cancer with Poor Performance Status and/or Severe Tumor-Related Complications by Kohei Shitara, Tomoya Yokota, Daisuke Takahari, Takashi Shibata, Yozo Sato, Masahiro Tajika, Takashi Ura, Kei Muro

Get full text

Cancer immunotherapy with PI3K and PD-1 dual-blockade via optimal modulation of T cell activation signal by Kohei Shitara, Yasuko Tada, Hiroyoshi Nishikawa, Daisuke Sugiyama, Sho Isoyama, Shigeyuki Mori, Yasuhiro Kojima, Kunihiko Hinohara, Shingo Dan

Get full text

Hypothyroidism and hypopituitarism as immune-related adverse events due to lenvatinib plus pembrolizumab therapy in the immediate postoperative period after laparoscopic hepatectom... by Kimimasa Sasaki, Shin Kobayashi, Masashi Kudo, Motokazu Sugimoto, Shinichiro Takahashi, Yoshiaki Nakamura, Akihito Kawazoe, Kohei Shitara, Takahiro Kinoshita, Naoto Gotohda

Get full text

Efficacy and safety of trifluridine/tipiracil plus bevacizumab and trifluridine/tipiracil or regorafenib monotherapy for chemorefractory metastatic colorectal cancer: a retrospecti... by Keigo Chida, Daisuke Kotani, Yoshiaki Nakamura, Akihito Kawazoe, Yasutoshi Kuboki, Kohei Shitara, Takashi Kojima, Hiroya Taniguchi, Jun Watanabe, Itaru Endo, Takayuki Yoshino

Get full text

A retrospective study of the safety and efficacy of paclitaxel plus ramucirumab in patients with advanced or recurrent gastric cancer with ascites by Hiroshi Matsumoto, Akihito Kawazoe, Kaoru Shimada, Shota Fukuoka, Yasutoshi Kuboki, Hideaki Bando, Takashi Kojima, Atsushi Ohtsu, Takayuki Yoshino, Toshihiko Doi, Kohei Shitara

Get full text

Retrospective cohort study of trifluridine/tipiracil (TAS-102) plus bevacizumab versus trifluridine/tipiracil monotherapy for metastatic colorectal cancer by Daisuke Kotani, Yasutoshi Kuboki, Satoshi Horasawa, Asumi Kaneko, Yoshiaki Nakamura, Akihito Kawazoe, Hideaki Bando, Hiroya Taniguchi, Kohei Shitara, Takashi Kojima, Akihito Tsuji, Takayuki Yoshino

Get full text

Correlation of multiple endpoints in the first‐line chemotherapy of advanced gastric cancer: Pooled analysis of individual patient data from Japanese Phase III trials by Hiroyuki Arai, Madoka Takeuchi, Wataru Ichikawa, Kohei Shitara, Yu Sunakawa, Koji Oba, Wasaburo Koizumi, Yuh Sakata, Hiroshi Furukawa, Yasuhide Yamada, Masahiro Takeuchi, Masashi Fujii

Get full text

Clinicopathological and molecular features of responders to nivolumab for patients with advanced gastric cancer by Saori Mishima, Akihito Kawazoe, Yoshiaki Nakamura, Akinori Sasaki, Daisuke Kotani, Yasutoshi Kuboki, Hideaki Bando, Takashi Kojima, Toshihiko Doi, Atsushi Ohtsu, Takayuki Yoshino, Takeshi Kuwata, Akihito Tsuji, Kohei Shitara

Get full text

Improved efficacy of taxanes and ramucirumab combination chemotherapy after exposure to anti-PD-1 therapy in advanced gastric cancer by Saori Mishima, Akihito Kawazoe, Yasutoshi Kuboki, Takashi Kojima, Toshihiko Doi, Takayuki Yoshino, Kohei Shitara, Yoshiaki Nakamura, Kentaro Sawada, Hiroya Taniguchi, Daisuke Kotani, Akinori Sasaki, Testuya Eto, Mashiro Okunaka, Tetsuo Akimoto

Get full text

Safety, tolerability, pharmacokinetics, and pharmacodynamics of the afucosylated, humanized anti-EPHA2 antibody DS-8895a: a first-in-human phase I dose escalation and dose expansio... by Kohei Shitara, Taroh Satoh, Satoru Iwasa, Kensei Yamaguchi, Kei Muro, Yoshito Komatsu, Tomohiro Nishina, Taito Esaki, Jun Hasegawa, Yasuyuki Kakurai, Emi Kamiyama, Tomoko Nakata, Kota Nakamura, Hayato Sakaki, Ichinosuke Hyodo

Get full text